Free Trial
NASDAQ:ESTA

Establishment Labs (ESTA) Stock Price, News & Analysis

Establishment Labs logo
$40.66 -2.97 (-6.81%)
Closing price 04:00 PM Eastern
Extended Trading
$40.72 +0.06 (+0.14%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Establishment Labs Stock (NASDAQ:ESTA)

Key Stats

Today's Range
$40.63
$43.37
50-Day Range
$33.62
$46.11
52-Week Range
$26.56
$50.85
Volume
353,846 shs
Average Volume
494,601 shs
Market Capitalization
$1.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.50
Consensus Rating
Moderate Buy

Company Overview

Establishment Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

ESTA MarketRank™: 

Establishment Labs scored higher than 37% of companies evaluated by MarketBeat, and ranked 704th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Establishment Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Establishment Labs has only been the subject of 4 research reports in the past 90 days.

  • Read more about Establishment Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for Establishment Labs are expected to grow in the coming year, from ($2.41) to ($1.83) per share.

  • Price to Book Value per Share Ratio

    Establishment Labs has a P/B Ratio of 21.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Establishment Labs' valuation and earnings.
  • Percentage of Shares Shorted

    18.48% of the float of Establishment Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Establishment Labs has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Establishment Labs has recently increased by 1.93%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Establishment Labs does not currently pay a dividend.

  • Dividend Growth

    Establishment Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.48% of the float of Establishment Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Establishment Labs has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Establishment Labs has recently increased by 1.93%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Establishment Labs has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Establishment Labs this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Establishment Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.44% of the stock of Establishment Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    72.91% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Establishment Labs' insider trading history.
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

ESTA Stock News Headlines

Contrasting Establishment Labs (NASDAQ:ESTA) and Aclarion (NASDAQ:ACON)
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
See More Headlines

ESTA Stock Analysis - Frequently Asked Questions

Establishment Labs' stock was trading at $46.07 at the beginning of 2025. Since then, ESTA stock has decreased by 11.7% and is now trading at $40.66.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings data on Thursday, August, 7th. The company reported ($0.57) EPS for the quarter, missing analysts' consensus estimates of ($0.54) by $0.03. Establishment Labs's revenue was up 16.1% compared to the same quarter last year.
Read the conference call transcript
.

Establishment Labs (ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Top institutional investors of Establishment Labs include Brown Advisory Inc. (7.40%), Nantahala Capital Management LLC (6.13%), Tyro Capital Management LLC (3.69%) and Bamco Inc. NY (3.13%). Insiders that own company stock include Nicholas Sheridan Lewin, Quiros Juan Jose Chacon, Raj Denhoy, Raj Denhoy and Leslie Gillin.
View institutional ownership trends
.

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Establishment Labs investors own include PayPal (PYPL), NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD) and Intel (INTC).

Company Calendar

Last Earnings
8/07/2025
Today
8/25/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ESTA
CIK
1688757
Fax
N/A
Employees
1,018
Year Founded
N/A

Price Target and Rating

High Price Target
$70.00
Low Price Target
$47.00
Potential Upside/Downside
+39.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$84.60 million
Net Margins
-49.89%
Pretax Margin
-49.32%
Return on Equity
-224.34%
Return on Assets
-25.53%

Debt

Debt-to-Equity Ratio
9.71
Current Ratio
2.84
Quick Ratio
1.67

Sales & Book Value

Annual Sales
$166.02 million
Price / Sales
7.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.90 per share
Price / Book
21.40

Miscellaneous

Outstanding Shares
28,970,000
Free Float
25,657,000
Market Cap
$1.18 billion
Optionable
Optionable
Beta
0.83

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:ESTA) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners